Kuczia Pawel, Zuk Joanna, Iwaniec Teresa, Soja Jerzy, Dropinski Jerzy, Malesa-Wlodzik Marta, Zareba Lech, Bazan Jan G, Undas Anetta, Bazan-Socha Stanislawa
Department of Internal Medicine, Jagiellonian University Medical College, 8 Skawinska Str, 31-066 Kraków, Poland.
Allergology and Pulmonology Clinic, Institute of Tuberculosis and Lung Diseases, Regional Branch in Rabka-Zdrój, Rabka-Zdrój, Poland.
Clin Transl Allergy. 2020 Jul 13;10:31. doi: 10.1186/s13601-020-00337-8. eCollection 2020.
Emerging data indicates that extracellular traps (ETs), structures formed by various immune cell types, may contribute to the pathology of noninfectious inflammatory diseases. Histone hypercitrullination is an important step in ETs formation and citrullinated histone H3 (H3cit) is considered a novel and specific biomarker of that process. In the present study we have evaluated circulating H3cit in stable asthmatics and investigated its relationship with asthma severity, pulmonary function and selected blood and bronchoalveolar lavage (BAL) biomarkers.
In 60 white adult stable asthmatics and 50 well-matched controls we measured serum levels of H3cit. In asthmatics we also performed bronchoscopy with BAL. We analyzed blood and BAL biomarkers, including interleukin (IL)-4, IL-5, IL-6, IL-10, IL-12p70, IL-17A and interferon γ. For statistical analysis, Mann-Whitney U-test, χ test, one-way ANCOVA, ROC curve analysis and univariate linear regression were applied. Independent determinants of H3cit were established in a multiple linear regression model.
Asthma was characterized by elevated circulating H3cit (17.49 [11.25-22.58] vs. 13.66 [8.66-18.87] ng/ml, p = 0.03). In asthmatics positive associations were demonstrated between serum H3cit and lung function variables, including total lung capacity (TLC) (β = 0.37 [95% CI 0.24-0.50]) and residual volume (β = 0.38 [95% CI 0.25-0.51]). H3cit was increased in asthma patients receiving systemic steroids (p = 0.02), as well as in subjects with BAL eosinophilia above 144 cells/ml (p = 0.02). In asthmatics, but not in controls, circulating H3cit correlated well with number of neutrophils (β = 0.31 [95% CI 0.19-0.44]) and monocytes (β = 0.42 [95% CI 0.29-0.55]) in peripheral blood. Furthermore, BAL macrophages, BAL neutrophils, TLC, high-sensitivity C-reactive protein, Il-12p70 and bronchial obstruction degree were independent determinants of H3cit in a multivariate linear regression model.
Asthma is characterized by increased circulating H3cit likely related to the enhanced lung ETs formation. Inhibition of ETs might be a therapeutic option in selected asthma phenotypes, such as neutrophilic asthma.
新出现的数据表明,由各种免疫细胞类型形成的细胞外陷阱(ETs)可能促成非感染性炎症性疾病的病理过程。组蛋白高瓜氨酸化是ETs形成的一个重要步骤,瓜氨酸化组蛋白H3(H3cit)被认为是该过程的一种新型特异性生物标志物。在本研究中,我们评估了稳定期哮喘患者循环中的H3cit,并研究了其与哮喘严重程度、肺功能以及选定的血液和支气管肺泡灌洗(BAL)生物标志物之间的关系。
在60名成年白人稳定期哮喘患者和50名匹配良好的对照者中,我们测量了血清H3cit水平。在哮喘患者中,我们还进行了BAL支气管镜检查。我们分析了血液和BAL生物标志物,包括白细胞介素(IL)-4、IL-5、IL-6、IL-10、IL-12p70、IL-17A和干扰素γ。进行统计分析时,应用了曼-惠特尼U检验、χ检验、单因素协方差分析、ROC曲线分析和单变量线性回归。在多元线性回归模型中确定了H3cit的独立决定因素。
哮喘的特征是循环中的H3cit升高(17.49 [11.25 - 22.58] 对13.66 [8.66 - 18.87] ng/ml,p = 0.03)。在哮喘患者中,血清H3cit与肺功能变量之间存在正相关,包括肺总量(TLC)(β = 0.37 [95% CI 0.24 - 0.50])和残气量(β = 0.38 [95% CI 0.25 - 0.51])。接受全身类固醇治疗的哮喘患者H3cit升高(p = 0.02),BAL嗜酸性粒细胞高于144个细胞/ml的受试者中H3cit也升高(p = 0.02)。在哮喘患者而非对照者中,循环中的H3cit与外周血中性粒细胞数量(β = 0.31 [95% CI 0.19 - 0.44])和单核细胞数量(β = 0.42 [95% CI 0.29 - 0.55])密切相关。此外,在多元线性回归模型中,BAL巨噬细胞、BAL中性粒细胞、TLC、高敏C反应蛋白、IL-12p70和支气管阻塞程度是H3cit的独立决定因素。
哮喘的特征是循环中的H3cit增加,这可能与肺内ETs形成增强有关。抑制ETs可能是某些哮喘表型(如嗜中性粒细胞性哮喘)的一种治疗选择。